Biogen BIIB
NASDAQ BIIB
$220.83 -3.68 (-1.64%)
At close: Sep 4, 2026 · 4:00 PM EDT

Biogen (BIIB) EV to CFO (2009 - 2026)

Biogen (BIIB) posted EV to CFO of 68.25 for Q2 2026, up 93.37% on a QoQ basis from 35.3 in Q1 2026, and down 29.85% year-over-year from 97.29 in Q2 2025.

Analysis

Biogen (BIIB) EV to CFO (2009 - 2026) Analysis & Trends

Biogen has reported EV to CFO for 18 years, with the latest figure at 68.25 in Q2 2026.

  • On a quarterly basis, EV to CFO fell 29.85% year-over-year to 68.25 in Q2 2026; TTM through Jun 2026 was 10.64, a 43.91% increase from a year earlier, with the FY2025 full-year figure at 9.99, up 44.17% from the prior year.
  • EV to CFO was 68.25 for Q2 2026 at Biogen, up from 35.3 in the prior quarter.
  • The five-year high for EV to CFO was 2915.67 in Q4 2023, with the low at 199.85 in Q4 2022.
  • Average EV to CFO over 5 years is 203.36, with a median of 52.86 recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: EV to CFO plunged 631.37% in 2022, then surged 1558.91% in 2023.
  • Over 5 years, EV to CFO stood at 199.85 in 2022, then soared by 1558.91% to 2915.67 in 2023, then sank by 99.1% to 26.18 in 2024, then jumped by 64.3% to 43.02 in 2025, then jumped by 58.67% to 68.25 in 2026.
  • The last three EV to CFO figures came in at 68.25 (Q2 2026), 35.3 (Q1 2026), and 43.02 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68.25
Mar 31, 2026 35.30
Dec 31, 2025 43.02
Sep 30, 2025 13.04
Jun 30, 2025 97.29
Mar 31, 2025 67.31
Dec 31, 2024 26.18
Sep 30, 2024 28.37
Jun 30, 2024 50.91
Mar 31, 2024 54.81
Dec 31, 2023 2,915.67
Sep 30, 2023 58.99
Jun 30, 2023 72.21
Mar 31, 2023 77.29
Dec 31, 2022 -199.85
Sep 30, 2022 50.72
Jun 30, 2022 33.66
Mar 31, 2022 167.30
Dec 31, 2021 37.61
Sep 30, 2021 48.51